|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date07 Dec 1967 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1959 |
|
MechanismHPRT1 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date11 Sep 1953 |
100 Clinical Results associated with Nova Laboratories Ireland Ltd.
0 Patents (Medical) associated with Nova Laboratories Ireland Ltd.
100 Deals associated with Nova Laboratories Ireland Ltd.
100 Translational Medicine associated with Nova Laboratories Ireland Ltd.